| Product Code: ETC7660389 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pyruvate Kinase Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pyruvate Kinase Market - Industry Life Cycle |
3.4 Israel Pyruvate Kinase Market - Porter's Five Forces |
3.5 Israel Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Israel Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pyruvate kinase deficiency in Israel |
4.2.2 Growing demand for advanced diagnostic tools for detecting pyruvate kinase disorders |
4.2.3 Rising investments in healthcare infrastructure and research development in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of pyruvate kinase testing kits |
4.3.2 Limited awareness among healthcare professionals and patients about pyruvate kinase disorders in Israel |
5 Israel Pyruvate Kinase Market Trends |
6 Israel Pyruvate Kinase Market, By Types |
6.1 Israel Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Israel Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Israel Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 Israel Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 Israel Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 Israel Pyruvate Kinase Market Export to Major Countries |
7.2 Israel Pyruvate Kinase Market Imports from Major Countries |
8 Israel Pyruvate Kinase Market Key Performance Indicators |
8.1 Adoption rate of pyruvate kinase diagnostic tests in Israel |
8.2 Number of research studies and clinical trials related to pyruvate kinase conducted in Israel |
8.3 Percentage of healthcare facilities offering pyruvate kinase testing services in Israel |
9 Israel Pyruvate Kinase Market - Opportunity Assessment |
9.1 Israel Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Israel Pyruvate Kinase Market - Competitive Landscape |
10.1 Israel Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 Israel Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here